Effects of Molecular Heterogeneity on Survival of Patients With <i>BRAF</i><sup>V600</sup>-Mutated Melanoma Treated With Vemurafenib With or Without Cobimetinib in the coBRIM Study.

Wongchenko, Matthew J; Ribas, Antoni; Ascierto, Paolo A; Dréno, Brigitte; Maria di Giacomo, Anna; Garbe, Claus; Chang, Ilsung; Hsu, Jessie; Rooney, Isabelle; Lu, William; Koeppen, Hartmut; Larkin, James; Yan, Yibing; McArthur, Grant A

Effects of Molecular Heterogeneity on Survival of Patients With BRAF^V600-Mutated Melanoma Treated With Vemurafenib With or Without Cobimetinib in the coBRIM Study.

Wongchenko, Matthew J; Ribas, Antoni; Ascierto, Paolo A; Dréno, Brigitte; Maria di Giacomo, Anna; Garbe, Claus; Chang, Ilsung; Hsu, Jessie; Rooney, Isabelle; Lu, William; Koeppen, Hartmut; Larkin, James; Yan, Yibing; McArthur, Grant A.

Afiliación

Wongchenko MJ; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Ribas A; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Ascierto PA; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Dréno B; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Maria di Giacomo A; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Garbe C; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Chang I; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Hsu J; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Rooney I; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Lu W; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Koeppen H; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Larkin J; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
Yan Y; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori
McArthur GA; Matthew J. Wongchenko, Ilsung Chang, Jessie Hsu, Isabelle Rooney, William Lu, Hartmut Koeppen, and Yibing Yan, Genentech, South San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, Los Angeles, CA; Paolo A. Ascierto, Istituto Nazionale Tumori

JCO Precis Oncol ; 2: 1-18, 2018 Nov.

Article en En | MEDLINE | ID: mdl-35135126

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article